Coronavirus (COVID-19) resources

Hepatitis B immune globulin for preventing hepatitis B recurrence after liver transplantation

We aim to assess the benefits and harms of HBIg after liver transplantation in HBV-infected patients.

We will try to find the minimal effective dose and time of the HBIg treatment in order to reduce the adverse effects as well as cost of the treatment.

This is a protocol.

You may also be interested in:

Hepatitis B immunoglobulin (HBIG) during pregnancy for the prevention of mother-to-child transmission of hepatitis B virus (HBV)
Hepatitis B vaccine, hepatitis B immunoglobulin, and hepatitis B vaccine plus immunoglobulin prevent perinatal transmission of hepatitis B
Immunoglobulins (human serum immune gamma globulins) seem effective for prevention of hepatitis A
Vaccines for preventing hepatitis B in healthcare workers (an updated protocol)
Bile acids may improve liver biochemistry of patients with hepatitis B or C, but there is insufficient evidence about long-term beneficial effects

Health topics:

Gastroenterology & hepatology > Liver disorders > Transplantation

Gastroenterology & hepatology > Liver disorders > Hepatitis B

Infectious disease > Liver infections > Hepatitis B

Don't show again

Close

What types and format of COVID-19 evidence is influencing your decision?

Take this short survey so Cochrane can better meet your needs in the future.